Labcorp Holdings Inc (LTS:0JSY)

$ 227.2 -2.98017 (-1.3%) Market Cap: 19.00 Bil Enterprise Value: 25.20 Bil PE Ratio: 44.11 PB Ratio: 2.33 GF Score: 81/100

Q1 2024 Laboratory Corporation of America Holdings Earnings Call Transcript
Apr 25, 2024

$197.29 (-4.42%)

Earnings
Q4 2023 Laboratory Corporation of America Holdings Earnings Call Transcript
Feb 15, 2024

$222.81 (-1.40%)

Earnings
Laboratory Corporation of America Holdings at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Q3 2023 Laboratory Corporation of America Holdings Earnings Call Transcript
Oct 26, 2023

$205.99 (+4.28%)

Earnings
Laboratory Corporation of America Holdings Investor Day Transcript
Sep 14, 2023
Q2 2023 Laboratory Corporation of America Holdings Earnings Call Transcript
Jul 27, 2023

$217.08 (-1.15%)

Earnings
Laboratory Corporation of America Holdings Investor Day Transcript
Jun 06, 2023
Laboratory Corporation of America Holdings Annual Shareholders Meeting Transcript
May 11, 2023
Q1 2023 Laboratory Corporation of America Holdings Earnings Call Transcript
Apr 25, 2023

$198.52 (-4.18%)

Earnings
Q4 2022 Laboratory Corporation of America Holdings Earnings Call Transcript
Feb 16, 2023

$214.22 (-1.80%)

Earnings
Laboratory Corporation of America Holdings at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Laboratory Corporation of America Holdings at Credit Suisse Healthcare Conference Transcript
Nov 08, 2022
Q3 2022 Laboratory Corporation of America Holdings Earnings Call Transcript
Oct 27, 2022

$194.66 (-4.34%)

Earnings
Laboratory Corporation of America Holdings at Robert W Baird Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Laboratory Corporation of America Holdings Earnings Call Transcript
Jul 28, 2022

$219.8

Earnings
Laboratory Corporation of America Holdings at UBS Global Healthcare Conference Transcript
May 24, 2022
Laboratory Corporation of America Holdings Annual Shareholders Meeting Transcript
May 11, 2022
Q1 2022 Laboratory Corporation of America Holdings Earnings Call Transcript
Apr 28, 2022

$210.33 (-4.39%)

Earnings
Q4 2021 Laboratory Corporation of America Holdings Earnings Call Transcript
Feb 10, 2022

$253.9 (+2.07%)

Earnings
Laboratory Corporation of America Holdings at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Laboratory Corporation of America Holdings at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2021
Q3 2021 Laboratory Corporation of America Holdings Earnings Call Transcript
Oct 28, 2021

$253.25 (+0.99%)

Earnings
Laboratory Corporation of America Holdings at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021
Q2 2021 Laboratory Corporation of America Holdings Earnings Call Transcript
Jul 29, 2021

$255.68 (+2.53%)

Earnings
Laboratory Corporation of America Holdings at UBS Global Healthcare Virtual Conference Transcript
May 24, 2021
Laboratory Corporation of America Holdings Annual Shareholders Meeting Transcript
May 12, 2021
Q1 2021 Laboratory Corporation of America Holdings Earnings Call Transcript
Apr 29, 2021

$237.52 (+1.70%)

Earnings
Laboratory Corporation of America Holdings at KeyBanc Capital Markets Life Sciences & Medtech Investor Forum (virtual) Transcript
Mar 24, 2021
Laboratory Corporation of America Holdings at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript
Feb 25, 2021
Q4 2020 Laboratory Corporation of America Holdings Earnings Call Transcript
Feb 11, 2021

$202.63

Earnings
Laboratory Corporation of America Holdings at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Laboratory Corporation of America Holdings at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 03, 2020
Laboratory Corporation of America Holdings at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2020
Q3 2020 Laboratory Corporation of America Holdings Earnings Call Transcript
Oct 27, 2020

$179.05

Earnings
Laboratory Corporation of America Holdings at Robert W Baird Global Healthcare Conference Transcript
Sep 09, 2020
Q2 2020 Laboratory Corporation of America Holdings Earnings Call Transcript
Jul 28, 2020

$176.37 (-0.76%)

Earnings
Laboratory Corporation of America Holdings at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 13, 2020
Laboratory Corporation of America Holdings Annual Shareholders Meeting Transcript
May 13, 2020
Q1 2020 Laboratory Corporation of America Holdings Earnings Call Transcript
Apr 29, 2020

$157.94 (+1.21%)

Earnings
Laboratory Corporation of America Holdings at Barclays Global Healthcare Conference Transcript
Mar 10, 2020
Q4 2019 Laboratory Corporation of America Holdings Earnings Call Transcript
Feb 13, 2020

$167.44 (+2.59%)

Earnings
Laboratory Corporation of America Holdings at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
Q3 2019 Laboratory Corporation of America Holdings Earnings Call Transcript
Oct 24, 2019

$148.83 (-0.83%)

Earnings
Laboratory Corporation of America Holdings at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019
Q2 2019 Laboratory Corporation of America Holdings Earnings Call Transcript
Jul 25, 2019

$151.67 (-4.24%)

Earnings
Laboratory Corporation of America Holdings Annual Shareholders Meeting Transcript
May 09, 2019
Q1 2019 Laboratory Corporation of America Holdings Earnings Call Transcript
Apr 30, 2019

$137.58

Earnings
Laboratory Corporation of America Holdings at Barclays Global Healthcare Conference Transcript
Mar 12, 2019
Q4 2018 Laboratory Corporation of America Holdings Earnings Call Transcript
Feb 07, 2019

$131.37 (+4.68%)

Earnings

Q1 2019 Laboratory Corporation of America Holdings Earnings Call Transcript

Apr 30, 2019 / 01:00PM GMT

Release Date Price: $137.58

Transcript 10-Q8-K

Operator

Good day, ladies and gentlemen, and welcome to the First Quarter 2019 LabCorp Holdings Earnings Conference Call. (Operator Instructions) As a reminder, this call is being recorded. I would now like to introduce your host for today's conference, Clarissa Willett, Vice President of Investor Relations. Please go ahead.

Clarissa Willett

- Vice President Investor Relations

Good morning, and welcome to LabCorp's First Quarter 2019 Conference Call. As detailed in today's press release, there will be a replay of this conference call available via telephone and Internet. With me today are Dave King, Chairman and Chief Executive Officer; Glenn Eisenberg, Executive Vice President and Chief Financial Officer; and John Ratliff, CEO of Covance Drug Development.

This morning, in the Investor Relations section of our website at www.labcorp.com, we posted both our press release and an Investor Relations presentation with additional information on our business and operations, which include a reconciliation

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.